Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

• A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented. • Intraperitoneal IL-2 was given with little toxicity. • Immunotherapy may have the potential for durable remissions in ovarian cancer.

Detalles Bibliográficos
Autores principales: Minor, David R., Moores, Samantha P., Chan, John K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633818/
https://www.ncbi.nlm.nih.gov/pubmed/29034306
http://dx.doi.org/10.1016/j.gore.2017.09.009
_version_ 1783269959787347968
author Minor, David R.
Moores, Samantha P.
Chan, John K.
author_facet Minor, David R.
Moores, Samantha P.
Chan, John K.
author_sort Minor, David R.
collection PubMed
description • A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented. • Intraperitoneal IL-2 was given with little toxicity. • Immunotherapy may have the potential for durable remissions in ovarian cancer.
format Online
Article
Text
id pubmed-5633818
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56338182017-10-13 Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer Minor, David R. Moores, Samantha P. Chan, John K. Gynecol Oncol Rep Case Report • A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented. • Intraperitoneal IL-2 was given with little toxicity. • Immunotherapy may have the potential for durable remissions in ovarian cancer. Elsevier 2017-09-25 /pmc/articles/PMC5633818/ /pubmed/29034306 http://dx.doi.org/10.1016/j.gore.2017.09.009 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Minor, David R.
Moores, Samantha P.
Chan, John K.
Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_full Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_fullStr Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_full_unstemmed Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_short Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
title_sort prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633818/
https://www.ncbi.nlm.nih.gov/pubmed/29034306
http://dx.doi.org/10.1016/j.gore.2017.09.009
work_keys_str_mv AT minordavidr prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer
AT mooressamanthap prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer
AT chanjohnk prolongedsurvivalafterintraperitonealinterleukin2immunotherapyforrecurrentovariancancer

Ejemplares similares